ÂÜÀòÂÒÂ×

Catie Corcoran currently serves as the Director of Communications at Texas Biomedical Research Institute since August 2024 and has held the position of Managing Director for Strategic Investor Communications at PCG Advisory Group since January 2021. Additionally, Catie is the Biotech Editor at Prism MarketView, a role commenced in August 2023. Previous experience includes serving as Account Director for Investor Communication at WE Communications from 2015 to 2020, Account Director at Mercom Capital Group in 2014-2015, and Director of Corporate Communications at Emirates Bank from 2009 to 2012. Catie began the career as a Senior Consultant at Capital MSL (Publicis Groupe) from 2007 to 2009. Academic credentials include a Bachelor of Arts and Sciences from the University of Melbourne, a Graduate Diploma of Public Relations from the London School of Public Relations, and studies at Northwestern University.